γδ-T Cell therapy(GD Kongming Biotech)

γδ-T细胞疗法（暨德康民生物）

Report date: 2024/07/27 20:00:03

Base Information

Drug Nameγδ-T Cell therapy(GD Kongming Biotech)

Drug Alias NameGDKM-100

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesGuangdong GD Kongming Biotech LLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGuangdong GD Kongming Biotech LLC

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A